These findings demonstrated that in situ expression of OCT4 in the SVZ increases the number of newly generated NSCs and OPCs but not the number of newly generated neurons and astrocytes in HD mice at 2 weeks post-treatment. The gene discussed is POU5F1; the disease is Huntington disease.